Clinical Trial Update: Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated detection of hypoxia in the thoracic aorta using the imaging agent pimonidazole hydrochloride; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Aortic Aneurysm

Drugs mentioned

• Pimonidazole hydrochloride (pimonidazole hydrochloride)

Snippet

Sponsor: Thomas Gleason | Conditions: Aortic Aneurysm, Thoracic | Phase 1 | Status: COMPLETED